Form 4: Vaxcyte CEO Transfers 100,000 Shares for Estate Planning

Vaxcyte, Inc. CEO Grant Pickering reported a gift of 100,000 common shares to an irrevocable trust for estate planning purposes.

Summary

• Vaxcyte, Inc. CEO Grant Pickering transferred 100,000 shares of common stock on January 14, 2026.
• The transaction was a gift (Transaction Code G) at a price of $0 per share.
• The shares were moved to an irrevocable trust established for estate planning purposes.
• Mr. Pickering disclaims beneficial ownership of these 100,000 shares following the transfer, indicating he no longer has a pecuniary interest.
• After this transaction, Mr. Pickering directly beneficially owns 400,908 shares of common stock.
• Additionally, 136,215 shares are held indirectly by a trust for the benefit of his son, and another 136,215 shares are held indirectly by a trust for the benefit of his daughter.

Sentiment

Score: 5

Explanation: The transaction is a personal estate planning gift by the CEO, not indicative of company performance or a change in management's confidence in the company's future. A gift is generally viewed neutrally to slightly positive compared to a sale, as it does not signal a lack of confidence.

Future Outlook

No forward-looking statements or guidance related to the company's performance were provided in this filing, as it pertains to a personal stock transaction.

Management Comments

• The reported transaction involves the Reporting Person's transfer of shares to an irrevocable trust for estate planning purposes.
• The Reporting Person no longer has a pecuniary interest in the shares and therefore disclaims beneficial ownership.

Industry Context

This filing details a personal estate planning transaction by the CEO and does not provide information relevant to broader industry trends or competitive landscape.

Related Party Transactions

• Grant Pickering, CEO, transferred 100,000 shares of common stock to an irrevocable trust for estate planning purposes.

Stakeholder Impact

• Shareholders are unlikely to experience a significant direct impact from this personal estate planning transaction by the CEO, as it does not reflect changes in company operations or financial health.

Key Dates

Recommendation

The filing details a personal estate planning transaction by the CEO, involving a gift of shares to an irrevocable trust. This type of transaction is generally considered neutral regarding the company's operational performance or future prospects and does not provide a basis for altering an investment recommendation.

Keywords

Vaxcyte, PCVX, Grant Pickering, SEC Form 4, Beneficial Ownership, Stock Transfer, Estate Planning, CEO, Common Stock